Prolieve (Medifocus)

Prolieve is a U.S. FDA approved treatment technology for benign prostatic hyperplasia (BPH), having successfully treated more than 80,000 patients without incidents.

Prolieve is a non-surgical, minimally invasive clinical treatment that takes about 45 to 60 minutes. There is hardly any side effects and most patients can resume normal life right after treatment. HMI is working to transfer this technology for production in China and at the same time, marketing this technology to other Asian countries such as Korea and Malaysia.